After more than a year of uncertainty surrounding U.S. foreign assistance, Washington has begun releasing nearly $2 billion in previously appropriated funding for international organizations working on childhood immunization, tuberculosis, hunger and other global priorities.
The most significant commitment came last week when the U.S. State Department notified Congress that it would release $600 million for Gavi, the Vaccine Alliance, restoring funding that had remained frozen following the Trump administration’s January 2025 pause on foreign assistance.
The decision follows the administration’s earlier move to withhold future U.S. support for Gavi and appears to signal a selective re-engagement with multilateral health initiatives. Reuters reported that the United States intends to return to Gavi’s board while evaluating future support against performance, accountability and agreed reforms. The administration also linked the funding to Gavi’s commitment to expand access to vaccines without thimerosal, although extensive scientific research has found no evidence that the preservative causes autism or other neurodevelopmental disorders.
While the funding releases are significant, they do not represent a return to the previous U.S. foreign assistance model. Instead, they coincide with a broader restructuring of how Washington intends to engage with governments on global health.
A Shift Toward Bilateral Partnerships
The administration’s America First Global Health Strategy places greater emphasis on negotiated government-to-government partnerships than on traditional donor programs.
Under the new framework, countries negotiate multi-year agreements that combine U.S. financial and technical assistance with commitments to increase domestic health investment, strengthen disease surveillance and assume greater long-term responsibility for financing and managing national health systems.
By April 2026, the State Department said it had signed 31 bilateral global health memoranda of understanding, reflecting a broader effort to shift from grant-based assistance toward partnerships built around shared responsibilities, measurable outcomes and long-term institutional capacity.
The Fiscal Challenge for Governments
The policy shift comes as governments face mounting pressure to finance larger shares of their own health systems.
The World Bank projects that development assistance for health could decline by approximately 20 percent by 2030, while combined government and donor health spending may fall below 2024 levels in more than 80 percent of low-income countries and 40 percent of lower-middle-income countries. Those projections highlight the fiscal challenge many governments could face as international partners increasingly emphasize domestic co-financing.
The broader direction is consistent with long-standing OECD recommendations that stronger country ownership is essential for sustainable development, while also recognizing that transitions away from donor financing must be carefully managed to avoid disrupting essential public services.
Health Security Becomes Foreign Policy
The strategy also reflects a broader evolution in U.S. foreign policy.
Rather than viewing global health primarily as development assistance, Washington increasingly frames investments in disease surveillance, outbreak detection and health system resilience as matters of national security and strategic engagement.
The World Health Organization has warned that recent reductions in external health financing have already disrupted vaccination, maternal care, disease surveillance and emergency preparedness across many low- and middle-income countries, underscoring that rebuilding health systems often takes considerably longer than restoring financial flows.
Diplomatic Outlook
For governments, the latest funding announcements suggest that U.S. engagement in global health is entering a new phase rather than returning to its previous form.
The immediate question is no longer whether Washington will continue to finance international health priorities—it has demonstrated that it will. The more consequential question is how those partnerships will be structured.
Governments seeking long-term cooperation with the United States may increasingly find that future agreements are shaped not only by development needs, but also by domestic investment, institutional capacity, measurable outcomes and alignment with broader strategic objectives. As this model evolves, health diplomacy is likely to become more closely integrated with foreign policy, fiscal policy and national resilience than at any point in recent decades.
RELATED STORIES:
Follow SDG News on LinkedIn
